Unknown

Dataset Information

0

Stepwise strategy for generating osteoblasts from human pluripotent stem cells under fully defined xeno-free conditions with small-molecule inducers.


ABSTRACT: Clinically relevant human induced pluripotent stem cell (hiPSC) derivatives require efficient protocols to differentiate hiPSCs into specific lineages. Here we developed a fully defined xeno-free strategy to direct hiPSCs toward osteoblasts within 21 days. The strategy successfully achieved the osteogenic induction of four independently derived hiPSC lines by a sequential use of combinations of small-molecule inducers. The induction first generated mesodermal cells, which subsequently recapitulated the developmental expression pattern of major osteoblast genes and proteins. Importantly, Col2.3-Cherry hiPSCs subjected to this strategy strongly expressed the cherry fluorescence that has been observed in bone-forming osteoblasts in vivo. Moreover, the protocol combined with a three-dimensional (3D) scaffold was suitable for the generation of a xeno-free 3D osteogenic system. Thus, our strategy offers a platform with significant advantages for bone biology studies and it will also contribute to clinical applications of hiPSCs to skeletal regenerative medicine.

SUBMITTER: Zujur D 

PROVIDER: S-EPMC6965656 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Stepwise strategy for generating osteoblasts from human pluripotent stem cells under fully defined xeno-free conditions with small-molecule inducers.

Zujur Denise D   Kanke Kosuke K   Onodera Shoko S   Tani Shoichiro S   Lai Jenny J   Azuma Toshifumi T   Xin Xiaonan X   Lichtler Alexander C AC   Rowe David W DW   Saito Taku T   Tanaka Sakae S   Masaki Hideki H   Nakauchi Hiromitsu H   Chung Ung-Il UI   Hojo Hironori H   Ohba Shinsuke S  

Regenerative therapy 20200114


Clinically relevant human induced pluripotent stem cell (hiPSC) derivatives require efficient protocols to differentiate hiPSCs into specific lineages. Here we developed a fully defined xeno-free strategy to direct hiPSCs toward osteoblasts within 21 days. The strategy successfully achieved the osteogenic induction of four independently derived hiPSC lines by a sequential use of combinations of small-molecule inducers. The induction first generated mesodermal cells, which subsequently recapitula  ...[more]

Similar Datasets

| S-EPMC8139978 | biostudies-literature
| S-EPMC5408455 | biostudies-literature
| S-EPMC5639211 | biostudies-literature
| S-EPMC5007071 | biostudies-literature
| S-EPMC3219112 | biostudies-literature
| S-EPMC4050355 | biostudies-literature
| S-EPMC3741356 | biostudies-literature
| S-EPMC4628790 | biostudies-literature
| S-EPMC2856688 | biostudies-literature
| S-EPMC3876251 | biostudies-literature